Jiangxi Xinganjiang Pharmaceutical CoBJSE:920367 60 Dividend Yield % is 0.14% as of Jul. 01, 2026, which is 86% below its 10-year median of 1.02. GuruFocus rates BJSE:920367 with a GF Score™ of 60/100 and a GF Value™ of ¥12.19 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 517 Drug Manufacturers companies, Jiangxi Xinganjiang Pharmaceutical Co ranks worse than 95.36% on this metric.
BJSE:920367'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.14 Med: 1.02 Max: 3.02
Current: 0.14
During the past 10 years, the highest Dividend Yield of Jiangxi Xinganjiang Pharmaceutical Co was 3.02%. The lowest was 0.14%. And the median was 1.02%.
BJSE:920367's Dividend Yield % is ranked worse than 95.36% of 517
companies
in the Drug Manufacturers industry
Industry Median: 2.04
vs BJSE:920367: 0.14
During the past 10 years, the highest Dividend Payout Ratio of Jiangxi Xinganjiang Pharmaceutical Co was 0.71. The lowest was 0.36. And the median was 0.43.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Yield % Chart
BJSE:920367 vs ZTS, UTHR: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangxi Xinganjiang Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangxi Xinganjiang Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Jiangxi Xinganjiang Pharmaceutical Co's Dividend Yield % falls into.
Jiangxi Xinganjiang Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Jiangxi Xinganjiang Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CNY 0.030000
2026-06-09
2026-06-08
2026-06-09
Cash Dividend
annually
CNY:CNY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) has a Dividend Yield % of 0.14% as of Jul. 01, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. This is 86% below median its historical median of 1.02. Over the past decade, Jiangxi Xinganjiang Pharmaceutical Co's Dividend Yield % has ranged from 0.14 to 3.02. According to the industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #493 out of 517 companies in the Drug Manufacturers industry, placing it in the top 95.4%.
Is Jiangxi Xinganjiang Pharmaceutical Co's Dividend Yield % too high?
Jiangxi Xinganjiang Pharmaceutical Co's current Dividend Yield % of 0.14% is 86% below median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 3.02. The Drug Manufacturers industry median Dividend Yield % is 2.04. Jiangxi Xinganjiang Pharmaceutical Co's value of 0.14% is 93.1% below this industry median. Based on the distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #493 out of 517 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Jiangxi Xinganjiang Pharmaceutical Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangxi Xinganjiang Pharmaceutical Co's Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangxi Xinganjiang Pharmaceutical Co ranks #493 out of 517 companies for Dividend Yield %. This places Jiangxi Xinganjiang Pharmaceutical Co in the lower half of its industry. The industry median Dividend Yield % is 2.04. Jiangxi Xinganjiang Pharmaceutical Co's value of 0.14% is 93.1% below this benchmark. Historically, Jiangxi Xinganjiang Pharmaceutical Co's own Dividend Yield % has ranged from 0.14 to 3.02 over the past decade. While the company's 10-year median is 1.02 vs. the industry median of 2.04, Jiangxi Xinganjiang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.04, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangxi Xinganjiang Pharmaceutical Co's current Dividend Yield % of 0.14% is 93.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Jiangxi Xinganjiang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangxi Xinganjiang Pharmaceutical Co's current Dividend Yield % is 0.14%, which is 86% below median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangxi Xinganjiang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥12.19, compared to a current price of ¥22.42 — trading 83.9% above its estimated fair value. The current Dividend Yield % is 0.14%, which is 86% below median its 10-year median of 1.02 and 93.1% below the Drug Manufacturers industry median of 2.04. Jiangxi Xinganjiang Pharmaceutical Co's overall GF Score™ is 60/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367), the current Dividend Yield % is 0.14% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangxi Xinganjiang Pharmaceutical Co (BJSE:920367) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangxi Xinganjiang Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥22.42 is trading 83.9% above its estimated GF Value™ of ¥12.19.
GuruFocus considers Jiangxi Xinganjiang Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for BJSE:920367:
Dividend Yield %: 0.14% (86% below median its 10-year median of 1.02)
GF Value™: ¥12.19 vs. price of ¥22.42 (83.9% above fair value)
Industry Position: 93.1% below the Drug Manufacturers median (#493 of 517)
No single metric tells the full story. See the BJSE:920367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangxi Xinganjiang Pharmaceutical Co Business Description
Jiangxi Xinganjiang Pharmaceutical Co Ltd conducts research and development, production, and sales of chemical raw materials, chemical preparations, and Chinese patent medicines. The company's raw material medicine products are mainly calcium gluconate, zinc gluconate, ferrous gluconate, and other gluconate series raw material medicines. Its main chemical preparations are vitamin C chewable tablets and compound Yinqiao aminomin capsules, and Phenaminokamin Tablets.
60GF Score
Get the complete analysis for BJSE:920367
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920367 has been successfully added to your 
